Literature DB >> 24969606

[Therapy for patients with dementia. Treatment strategies in the elderly].

F Jessen1.   

Abstract

BACKGROUND: The number of patients with dementia is increasing. There is often uncertainty about adequate treatment.
OBJECTIVES: In this paper, current treatment recommendations for dementia are summarized.
MATERIAL AND METHODS: The basis of the article is the S3 guideline on dementia from the Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN) and Deutschen Gesellschaft für Neurologie (DGN). In addition, newer therapeutic approaches and recent publications have been taken into consideration.
RESULTS: Before the initiation of treatment, a meaningful differential diagnosis is required to identify potentially reversible causes of dementia syndrome and to determine the correct treatment for specific dementia types. For Alzheimer's disease, acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmin) and memantine are efficacious and provide patient-related benefit. For other dementia types, there is evidence for efficacy of these drugs in some cases. Neuropsychiatric symptoms should first be managed by individual counseling and caregivers education and support. If this is not sufficiently effective, individual psychopharmacological drugs are available for specific conditions. DISCUSSION: Dementia can not be cured, but current treatment can achieve relief of disease burden and improve quality of life for patients and caregivers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24969606     DOI: 10.1007/s00108-014-3465-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  26 in total

Review 1.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

2.  Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.

Authors:  Daniel Weintraub; Paul B Rosenberg; Lea T Drye; Barbara K Martin; Constantine Frangakis; Jacobo E Mintzer; Anton P Porsteinsson; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2010-04       Impact factor: 4.105

3.  Donepezil and memantine for moderate-to-severe Alzheimer's disease.

Authors:  Robert Howard; Rupert McShane; James Lindesay; Craig Ritchie; Ashley Baldwin; Robert Barber; Alistair Burns; Tom Dening; David Findlay; Clive Holmes; Alan Hughes; Robin Jacoby; Rob Jones; Roy Jones; Ian McKeith; Ajay Macharouthu; John O'Brien; Peter Passmore; Bart Sheehan; Edmund Juszczak; Cornelius Katona; Robert Hills; Martin Knapp; Clive Ballard; Richard Brown; Sube Banerjee; Caroline Onions; Mary Griffin; Jessica Adams; Richard Gray; Tony Johnson; Peter Bentham; Patrick Phillips
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

4.  Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia.

Authors:  Nathan Herrmann; Sandra E Black; Tiffany Chow; Jaclyn Cappell; David F Tang-Wai; Krista L Lanctôt
Journal:  Am J Geriatr Psychiatry       Date:  2012-09       Impact factor: 4.105

Review 5.  Neuropathological evaluation of mixed dementia.

Authors:  K A Jellinger; J Attems
Journal:  J Neurol Sci       Date:  2007-02-26       Impact factor: 3.181

6.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

7.  Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial.

Authors:  Philip Scheltens; Patrick J G H Kamphuis; Frans R J Verhey; Marcel G M Olde Rikkert; Richard J Wurtman; David Wilkinson; Jos W R Twisk; Alexander Kurz
Journal:  Alzheimers Dement       Date:  2010-01       Impact factor: 21.566

8.  The decreasing prevalence of reversible dementias: an updated meta-analysis.

Authors:  A Mark Clarfield
Journal:  Arch Intern Med       Date:  2003-10-13

9.  Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Authors:  Constantine G Lyketsos; Lourdes DelCampo; Martin Steinberg; Quincy Miles; Cynthia D Steele; Cynthia Munro; Alva S Baker; Jeannie-Marie E Sheppard; Constantine Frangakis; Jason Brandt; Peter V Rabins
Journal:  Arch Gen Psychiatry       Date:  2003-07

10.  Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Authors:  Pierre N Tariot; Martin R Farlow; George T Grossberg; Stephen M Graham; Scott McDonald; Ivan Gergel
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.